Synolo Therapeutics
PrivateCompany Overview
Synolo Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. It was founded in 2023.
Synolo Therapeutics is a biotechnology company that develops precision-targeted, conditionally-active immunotherapies for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synolo Therapeutics Comparables
Compare Synolo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tentarix Biotherapeutics | 84% | |
| Archon Biosciences | 84% | |
| Plectonic Biotech | 83% |
For institutional investors. Book with your work email.
Synolo Therapeutics Funding Rounds
Historical fundraising activity
Synolo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Raven (RA Capital's healthcare incubator) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 86% MoM.
- May 14, 2026
Monthly visitors grew 2658% MoM, from 26 to 717.
For institutional investors. Book with your work email.
Synolo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synolo Therapeutics's valuation, stock price, and market status.
Is Synolo Therapeutics a public or private company?
Synolo Therapeutics is a private company.
What is the current stock price of Synolo Therapeutics?
Synolo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Synolo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synolo Therapeutics worth (valuation)?
Valuation information for Synolo Therapeutics is not publicly available.
Can I buy Synolo Therapeutics stock?
Synolo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synolo Therapeutics's last funding round?
Funding round information for Synolo Therapeutics is not publicly available.
Who are the main investors in Synolo Therapeutics?
Key investors in Synolo Therapeutics include Raven (RA Capital's healthcare incubator).
Will Synolo Therapeutics IPO soon?
No public IPO plans have been announced for Synolo Therapeutics.
How can I track Synolo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Synolo Therapeutics's shares on secondary markets.